Btc Capital Management Lowers stake in Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX) : Btc Capital Management reduced its stake in Quest Diagnostics Inc by 1.24% during the most recent quarter end. The investment management company now holds a total of 52,050 shares of Quest Diagnostics Inc which is valued at $4,458,083 after selling 656 shares in Quest Diagnostics Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Quest Diagnostics Inc makes up approximately 0.94% of Btc Capital Management’s portfolio.

Other Hedge Funds, Including , California State Teachers Retirement System reduced its stake in DGX by selling 5,453 shares or 1.74% in the most recent quarter. The Hedge Fund company now holds 308,394 shares of DGX which is valued at $26,413,946. Quest Diagnostics Inc makes up approx 0.06% of California State Teachers Retirement System’s portfolio.Smithfield Trust Co boosted its stake in DGX in the latest quarter, The investment management firm added 1,700 additional shares and now holds a total of 3,752 shares of Quest Diagnostics Inc which is valued at $324,023. Quest Diagnostics Inc makes up approx 0.06% of Smithfield Trust Co’s portfolio.Shell Asset Management Co boosted its stake in DGX in the latest quarter, The investment management firm added 2,391 additional shares and now holds a total of 61,648 shares of Quest Diagnostics Inc which is valued at $5,197,543. Quest Diagnostics Inc makes up approx 0.12% of Shell Asset Management Co’s portfolio.Breton Hill Capital Ltd. reduced its stake in DGX by selling 3,082 shares or 24.41% in the most recent quarter. The Hedge Fund company now holds 9,545 shares of DGX which is valued at $793,190. Quest Diagnostics Inc makes up approx 0.25% of Breton Hill Capital Ltd.’s portfolio.

Quest Diagnostics Inc opened for trading at $85.86 and hit $85.95 on the upside on Thursday, eventually ending the session at $85.8, with a gain of 0.18% or 0.15 points. The heightened volatility saw the trading volume jump to 9,43,287 shares. Company has a market cap of $11,928 M.

On the company’s financial health, Quest Diagnostics Inc reported $1.34 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 21, 2016. Analyst had a consensus of $1.32. The company had revenue of $1906.00 million for the quarter, compared to analysts expectations of $1905.57 million. The company’s revenue was down -1.0 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.25 EPS.

Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business consists of two parts develops and delivers diagnostic testing information and services to patients physicians health plans hospitals accountable care organizations (ACOs) integrated delivery networks (IDNs) other commercial laboratories patients and other customers. Diagnostics Information Services business also provides diagnostic information services which includes providing clinical testing services such as routine testing gene-based and esoteric testing anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Company’s other businesses including central laboratory testing for pharmaceutical and medical device clinical trials risk assessment services diagnostic products and healthcare information technology.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *